Renu Virmani MD
Clinical Professor, Department of Pathology: Georgetown University, Washington, DC; University of Maryland–Baltimore, Baltimore, Maryland; George Washington University, Washington, DC; and Vanderbilt University, Nashville, Tennessee; President and Medical Director, CVPath Institute, Gaithersburg, MarylandDr. Virmani is an internationally renowned cardiovascular pathologist. She is recognized as a leading researcher in the field of cardiovascular disease treatments.
Currently Dr. Virmani serves as the President and Medical Director of CVPath Institute, which she founded in 2005. Dr. Virmani lectures at scientific meetings, both nationally and internationally, and has delivered more than 800 presentations globally. She is responsible for multiple research grants in the field of cardiovascular pathology and has authored or co-authored over 600 publications in peer-reviewed journals in the field of atherosclerosis, vulnerable plaque, stents, and other cardiovascular diseases. She has edited 7 books and written over 100 book chapters. Dr. Virmani is also a manuscript reviewer for many scientific journals.
Dr. Virmani was recently recognized by the Council on Clinical Cardiology of the American Heart Associations and also delivered the Laennec Clinician Educator Lecture in 2010. She was awarded an honorary degree from the University of Antwerp, Belgium in 2008 and has also received honorary awards from European Society of Cardiology (2008) and EuroPCR (2006).
Dr. Virmani is also Clinical Professor, Department of Pathology at Georgetown University; University of Maryland-Baltimore; George Washington University; and Vanderbilt University. She was a Chairperson at the Department of Cardiovascular Pathology of the Armed Forces Institute of Pathology from 1984 until 2004. Dr. Virmani is a member of the American Heart Association, the U.S. and Canadian Academy of Pathology, and is a Fellow of the American College of Cardiology. Dr. Virmani received her M.D. from Lady Hardinge Medical College, Delhi University, in New Delhi, India.
Recent Contributions to PracticeUpdate:
- Alirocumab Is Associated With Greater Plaque Burden Regression in Patients With Familial Hypercholesterolemia
- Association Between Coronary Atherosclerotic Plaque Activity and Future Coronary Events
- COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart
- Predictors of Rapid Plaque Progression
- Autopsy Findings and VTE in Patients With COVID-19
- High-Density Calcified 1K Plaque Associated With Reduced Risk of Acute Coronary Syndrome
- Neoatherosclerosis in Patients With Coronary Stent Thrombosis
- Longitudinal Lesion Geometry Is Associated With Location of Plaque Rupture and Clinical Presentations
- Mechanisms of Stent Thrombosis Analyzed by Optical Coherence Tomography
- Mechanisms of Very Late Drug-Eluting Stent Thrombosis